Irena is the Chief Financial Officer of aMoon, where she brings over 15 years of finance management experience in public companies and business units of global enterprises. Irena provides finance and operations support to all functions within the organization, assists senior management in financial planning and results management, leads financial and tax due diligence processes, and analyzes portfolio companies financial and business results.
Prior to joining aMoon, Irena was the VP Finance of Alcobra (NASDAQ: ADHD) a development-stage biotech company where she led the financial aspects of Alcobra’s operations, playing a key role in Public equity offering and Alcobra’s merger with Arcturus Therapeutics (NASDAQ: ARCT), a San-Diego based mRNA company.
Prior to joining Alcobra, she was Finance Manager at Omrix Biopharmaceuticals, a Johnson & Johnson company. There she spent 7 years in various finance positions.
Irena is passionate about being part of an organization which enables companies to develop technologies which may save lives.
Irena is a Certified Public Accountant and holds a B.A. in Economics and Accounting from the Hebrew University of Jerusalem and an M.B.A. from Tel Aviv University.